Literature DB >> 30237301

Spinal Imaging Findings of Open Spinal Dysraphisms on Fetal and Postnatal MRI.

U D Nagaraj1, K S Bierbrauer2, C B Stevenson2, J L Peiro3, F Y Lim3, B Zhang4,5, B M Kline-Fath4.   

Abstract

BACKGROUND AND
PURPOSE: Fetal MRI has become a valuable tool in the evaluation of open spinal dysraphisms making studies comparing prenatal and postnatal MRI findings increasingly important. Our aim was to determine the accuracy of predicting the level of the spinal dysraphic defect of open spinal dysraphisms on fetal MR imaging and to report additional findings observed when comparing fetal and postnatal MR imaging of the spine in this population.
MATERIALS AND METHODS: A single-center retrospective analysis was performed of fetal MRIs with open spinal dysraphisms from 2004 through 2016 with available diagnostic postnatal spine MR imaging. Images were reviewed by 2 board-certified fellowship-trained pediatric neuroradiologists. Corresponding clinical/operative reports were reviewed.
RESULTS: One hundred nineteen fetal MRIs of open spinal dysraphisms were included. The level of the osseous defect between fetal and postnatal MR imaging was concordant in 42.9% (51/119) of cases and was 1 level different in 39% (47/119) of cases. On postnatal MR imaging, type II split cord malformation was seen in 8.4% (10/119) of cases, with only 50% (5/10) of these cases identified prospectively on fetal MR imaging. Syrinx was noted in 3% (4/119) of prenatal studies, all cervical, all confirmed on postnatal MR imaging.
CONCLUSIONS: Fetal MR imaging is accurate in detecting the level of the spinal dysraphic defect, which has an impact on prenatal counseling, neurologic outcomes, and eligibility for fetal surgery. In addition, fetal MR imaging is limited in its ability to detect split cord malformations in patients with open spinal dysraphisms. Although rare, fetal MR imaging has a high specificity for detection of cervical spinal cord syrinx.
© 2018 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2018        PMID: 30237301     DOI: 10.3174/ajnr.A5760

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

Review 1.  Imaging of open spinal dysraphisms in the era of prenatal surgery.

Authors:  Usha D Nagaraj; Beth M Kline-Fath
Journal:  Pediatr Radiol       Date:  2020-11-30

Review 2.  The Perplexity Surrounding Chiari Malformations - Are We Any Wiser Now?

Authors:  S B Hiremath; A Fitsiori; J Boto; C Torres; N Zakhari; J-L Dietemann; T R Meling; M I Vargas
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

Review 3.  Unveiling the tale of the tail: an illustration of spinal dysraphisms.

Authors:  Anjuna Reghunath; Rohini Gupta Ghasi; Ankita Aggarwal
Journal:  Neurosurg Rev       Date:  2019-12-07       Impact factor: 3.042

4.  Use of magnetic resonance imaging in the diagnosis of fetal vertebral abnormalities in utero: a single-center retrospective cohort study.

Authors:  Xianyun Cai; Xin Chen; Xinhong Wei; Wen Liu; Ximan Hou; Tao Gong; Jinxia Zhu; Ewart Mark Haacke; Guangbin Wang
Journal:  Quant Imaging Med Surg       Date:  2022-06

5.  Ascent of the conus medullaris in human foetuses: a systematic review and meta-analysis.

Authors:  Lucas Costa Almeida; Yasmin Juliany de Souza Figueiredo; André Pinheiro Zylberman; Diogo Costa Garção
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

Review 6.  Value of pre- and postnatal magnetic resonance imaging in the evaluation of congenital central nervous system anomalies.

Authors:  Usha D Nagaraj; Charu Venkatesan; Karin S Bierbrauer; Beth M Kline-Fath
Journal:  Pediatr Radiol       Date:  2021-07-07

7.  Myelomeningocele-Chiari II malformation-Neurological predictability based on fetal and postnatal magnetic resonance imaging.

Authors:  Farjad Khalaveh; Rainer Seidl; Thomas Czech; Andrea Reinprecht; Gerlinde Maria Gruber; Angelika Berger; Herbert Kiss; Daniela Prayer; Gregor Kasprian
Journal:  Prenat Diagn       Date:  2021-06-19       Impact factor: 3.050

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.